WHAT IS MACULAR DEGENERATİON ?
İçerik yapay zeka ile optimize edilmiştir
What is Age-Related Macular Degeneration (AMD)?
Age-related macular degeneration (AMD) is a progressive eye disorder primarily driven by the aging process. It specifically affects the macula, leading to various conditions that impair visual health. As the leading cause of vision loss in older adults, understanding its mechanisms and symptoms is crucial for early intervention.
The Role of the Macula in Central Vision
The macula, often referred to as the ‘yellow spot’, is a specialized, minute region of the retina. It contains a high concentration of photoreceptor cells (cone cells), which are responsible for central sight, distinguishing fine details, and perceiving colors in bright lighting conditions.
Surrounding the central macula is the peripheral macula, which consists of rod cells. These cells facilitate vision in dim lighting and manage sight outside the direct line of vision. When AMD occurs, these specialized functions are compromised, leading to significant visual impairment.
Key Symptoms and Consequences of AMD
The primary result of AMD is the loss of central vision. This deterioration manifests through several specific visual challenges:
- Decreased Visual Acuity: Loss of fine detail makes daily tasks like reading and driving increasingly difficult.
- Decreased Contrast Sensitivity: Difficulty in distinguishing between objects and backgrounds.
- Visual Distortion: Straight lines may appear wavy, and recognizing facial features becomes challenging.
- Night Glare: An increased sensitivity to bright lights during nighttime.
- Blind Spots: Dark areas appear in the central field of vision, which can grow in size if the condition remains untreated.
Classifying AMD: Dry vs. Wet Forms
Medical professionals categorize AMD into two distinct types based on their progression and underlying pathology:
1. Dry AMD (Non-neovascular)
Dry AMD is the most prevalent form of the disease. It occurs due to the gradual breakdown, thinning, and aging of retinal epithelial cells within the macula. Also known as atrophic macular degeneration, it is characterized by the slow death (atrophy) of macular cells over time.
2. Wet AMD (Neovascular or Exudative)
Although less common than the dry form, Wet AMD is significantly more rapid and severe. Without treatment, central vision can deteriorate within days. In this form, retinal pigment cells degenerate, prompting the growth of abnormal blood vessels from the choroid (choroidal neovascularization). These fragile vessels often leak blood and fluid, eventually causing permanent scarring in the macula.
Advanced Treatment Modalities for Wet AMD
While there are currently no treatments to stop the progression of dry AMD, several therapies have been developed to manage Wet AMD and prevent further vision loss:
| Treatment Method | Procedure Overview | Mechanism of Action |
|---|---|---|
| Photodynamic Therapy | Injection of Verteporfin followed by low-power laser application. | Activates the medication to destroy abnormal vessels without damaging surrounding tissue. |
| Anti-VEGF Therapy | Intraocular administration of drugs like Ranibizumab or Bevacizumab. | Blocks Vascular Endothelial Growth Factor (VEGF) to prevent new vessel formation. |
| Laser Treatment | High-energy laser beam focused on the affected retinal area. | Directly targets and destroys newly-formed abnormal blood vessels. |
Monitoring and Diagnosis: The Amsler Grid
Regular monitoring is essential for patients at risk of or living with AMD. The Amsler Grid test is a vital diagnostic tool used to detect early signs of distortion. If straight lines appear wavy or certain areas of the grid disappear, it serves as a critical indication of AMD progression.
Op. Dr. Ahmet UMAY
Bristol University / Ophthalmology Section, UK
Reference: news-medical.net
